Royce & Associates公司购买了70多万股Absci股份, Royce & Associates buys over 700,000 Absci shares, betting on AI biotech despite financial struggles.

Royce & Associates公司大幅增加了对Absci Co.的投资,Absci Co.是一家生物技术公司,利用AI开发生物学,另外购买了70多万股。 Royce & Associates has significantly increased its investment in Absci Co., a biotech firm that uses AI to develop biologics, buying over 700,000 additional shares. 尽管最近财政指标呈负数,分析师仍对公司保持“Buy”评级,目标价格为8.57美元。 Despite recent negative financial metrics, analysts maintain a "Buy" rating on the company, with a target price of $8.57. Absci的平台将AI与实验室技术相结合,以改进毒品生产过程。 Absci's platform combines AI with lab technologies to improve drug creation processes.